Introduction
Antimicrobial resistance (AMR) is a global health threat with projections of over eight million annual deaths associated with AMR by 2050 [Reference Naghavi1]. Six strains of bacteria, including Escherichia coli (E. coli), Streptococcus pneumoniae, Staphylococcus aureus (S. aureus), Klebsiella pneumoniae, Acinetobacter baumannii (A. baumannii), and Pseudomonas aeruginosa (P. aeruginosa), account for more than 80% of AMR-attributed mortality worldwide [Reference Naghavi1]. Intensive care units (ICUs) represent high-risk settings, where AMR infections contribute to nearly 80% mortality rates [Reference Saharman2] and 50% of hospital-acquired infections (HAI) [Reference Vincent3]. The coronavirus disease 2019 (COVID-19) pandemic leveraged AMR challenges when antibiotic use was reported in 75% of admissions and bacterial AMR was found in 60.8% of infections among COVID-19 patients [Reference Langford4].
In Vietnamese hospital ICUs, studies reported alarming AMR rates and multidrug resistance (MDR) [Reference Kinh5–Reference Vu7], particularly among gram-negative bacteria, with 30%–70% resistance to third- and fourth-generation cephalosporins, aminoglycosides, and fluoroquinolones [6]. Similar trends in low-and middle-income countries (LMICs), such as India, China, and Pakistan, highlight the pandemic’s role in exacerbating AMR through antibiotic overuse and overwhelmed healthcare systems [Reference Balasubramanian8].
While high-income countries increasingly applied electronic medical records (EMRs) and Machine Learning (ML) to predict AMR patterns, optimize antibiotic use, and reduce AMR rates in hospital settings [Reference Luz9], LMICs like Vietnam face implementation limitations [Reference Lv, Deng and Zhang10]. Few hospitals integrate antibiotic susceptibility tests (AST) into EMRs, challenging real-time and systematic AMR surveillance. This study was conducted in ICUs of two Vietnamese hospitals (Phu Tho Hospital, 175 Hospital), aiming to determine the AMR prevalence among five high-priority bacterial pathogens (E. coli, S. aureus, Klebsiella species, Acinetobacter species, P. aeruginosa) and identify its associated factors during the COVID-19 pandemic.
Methods
Study design and settings
This retrospective cross-sectional study analysed EMRs from ICU patients at the Phu Tho Provincial General Hospital (Phu Tho Hospital) and the Military Hospital 175 (175 Hospital). These hospitals were selected purposively [Reference Etikan11], in which Phu Tho Hospital was in the Northern, rural, and mountainous region, meanwhile, 175 Hospital was in the Southern, urban, and densely populated region. In the 2020s, the gross regional domestic product per capita in Phu Tho Province and Ho Chi Minh City was 2,184 and 6,405 USD, respectively [12, 13]. While 175 Hospital serves military personnel, it also treated civilians, especially during the COVID-19 pandemic [Reference Choi14, Reference Hai15]. Phu Tho Hospital did not treat the COVID-19 patients during the period of study (2020–2022).
EMRs of patients aged ≥18 years upon admission with positive bacterial cultures in the ICUs were collected from 1 January 2020, to 30 June 2022, covering four COVID-19 waves in Vietnam [Reference Trang16]). Wave 1 (January–July 2020, imported cases, no deaths); Wave 2 (July–December 2020, the first epidemic wave with local transmission, 35 deaths); Wave 3 (January–March 2021, imported Alpha variant, no fatalities); and Wave 4 (April 2021–March 2022, Delta variants, approximately 32,000 deaths [Reference Trang16]).
Viral infections and fungal isolates were excluded, duplicate bacterial isolates (defined as those of the same species and susceptibility profiles from the same patient at admission) were removed to ensure unique observation and prevent overestimations. Extracted data included patient demographics (e.g., age, sex), clinical history (initial diagnosis, time of bacterial isolation), and AST results.
Sample size
From 3,965 AST samples recorded over two and a half years, 2,432 non-duplicated bacterial samples were analysed after excluding fungal samples and duplicates, including 856 from Phu Tho Hospital and 1,576 from 175 Hospital. These samples originated from 1,625 EMRs of 1,296 ICU patients (600 from Phu Tho Hospital and 696 from 175 Hospital).
Patterns of antibiotic resistance
Antibiotic resistance patterns were assessed based on AST results, with samples categorized into eight types: sputum, blood, fluid (e.g., tracheobronchial aspirates, cerebrospinal fluid, pleural fluid), catheter, tissue (skin, wound, and soft tissue specimens), urine, faeces, and unknown. Variables included isolation date, sample type, bacterial species, and resistance profiles. MDR strains were defined as resistance to at least one antibiotic in three or more antibiotic classes [Reference Magiorakos17].
Antibiotic susceptibility testing
ASTs were conducted using the VITEK2 Compact system at Phu Tho Hospital and the BD Phoenix 100 system at 175 Hospital, combined with disk diffusion, gradient diffusion, and broth microdilution methods at both sites [18, 19]. Both testing systems adhered to the Clinical and Laboratory Standards Institute (CLSI) 2020 guidelines [20] and Vietnam’s Ministry of Health protocol of the Ministry of Health of Vietnam (Decision No. 127/QD-BYT, 2019) under the Vietnam Antimicrobial Resistance Surveillance System [21].
Enzyme production, including extended-spectrum beta-lactamases (ESBL) and carbapenemases, was identified through biochemical assays in VITEK 2 and BD Phoenix system [Reference Neil22]. For S. aureus, resistance to oxacillin and cefoxitin was determined by minimum inhibitory concentration (MIC) with thresholds of >2 μg/mL for oxacillin and > 4 μg/mL for cefoxitin, following CLSI standards [20, Reference Junkins23] The methicillin-resistant S. aureus (MRSA) rate was calculated as the percentage of S. aureus isolates that were resistant to either oxacillin or cefoxitin out of the total number of S. aureus isolates tested for these antibiotics [24].
Bacterial and antibiotic categories
Targeted bacteria included Acinetobacter species (A. baumannii, Acinetobacter lwoffii, A. hemolyticus, Acinetobacter junii), Klebsiella species (Klebsiella pneumoniae, Klebsiella oxytoca, Klebsiella aerogenes, K. ozaena), P. aeruginosa, E. coli, and S. aureus as per American Type Culture Collection (ATCC) standards [25]. ASTs covered 25 antibiotic families according to WHO guidelines [26].
Covariates
Covariates included demographic factors (age, sex, and location of residence) and clinical indicators (admission diagnoses coded by ICD-10, month, and year of test intake). These variables were chosen for their established links to AMR in ICU settings, which were explored as potential confounders in previous studies [Reference Luz9, Reference Lv, Deng and Zhang10].
Statistical analysis
Data were cleaned, preprocessed, and analysed in Python 3.12, using packages like Pandas, Numpy, Statsmodels, Matplotlib, Seaborn, and Scikit-learn [Reference Raschka and Mirjalili27]. We analysed datasets separately to compare AMR patterns between hospitals, while using combined data for temporal trend analysis and assessing associations between clinical factors and AMR prevalence. For temporal analysis, we aggregated data by month and year of specimen collection (AST intake date) across both hospitals over the study period (2020–2022) to examine resistance trends over time. In addition, we conducted a separate analysis focused on COVID-19-specific trends by evaluating data from COVID-19 patients at 175 Hospital.
A supervised machine learning approach, specifically a logistic regression model with 1,000 bootstrap resamples, was used to assess demographic and clinical factors associated with AMR prevalence [Reference Raschka and Mirjalili27]. Potential confounders, including age, sex, admission diagnosis, residence location, and time of AST intake, were simultaneously included in the model to adjust for their effects.
Categorical variables (e.g., year, month, location) were transformed into binary (0/1) formats using label and one-hot encoding, where 1 indicated the presence of a characteristic (e.g., admission in 2020) and 0 its absence. To assess multicollinearity, we conducted variance inflation factor (VIF) analysis after removing redundant categories; all resulting VIF values were below five (range: 1.01–3.68), indicating no significant multicollinearity (Supplementary Table S2) [Reference Kim28]. Model coefficients and their 95% confidence intervals (CIs) were calculated using bootstrap resampling to ensure robust effect estimates [Reference Raschka and Mirjalili27].
Results
AMR prevalence and trends of five targeted bacteria among ICU patients
In Table 1, the ICU patients with positive bacterial culture had a mean age of 60 years (interquartile range – IQR from 50 to 70), with more men than women admitted at both hospitals. Notably, COVID-19 patients were exclusive to 175 Hospital. From 2020 to 2022, respiratory diseases (37.2%) and unclassified diseases (34.7%) were primary admission diagnoses at Phu Tho Hospital, while COVID-19 and respiratory diseases were predominant at 175 Hospital (25.1% and 28.7%, respectively). Infections with five targeted bacteria occurred in 83.7% of ICU patients in Phu Tho Hospital and 92.1% in 175 Hospital, with Acinetobacter spp. and Klebsiella spp. most prevalent. At 175 Hospital, the median hospital lengths and ICU stays were 13 days (IQR 8–22) and 11 days (IQR 6–17), respectively.
Characteristics of ICU patients with positive bacterial culture results at Phu Tho Hospital (n = 600) and 175 Hospital (n = 696)
a Other diseases included diseases of the musculoskeletal system; endocrine diseases; neoplasms; skin, blood, and immune mechanism; mental disorders; and external causes of morbidity.
ICU: Intensive Care Unit, COVID-19: Coronavirus Disease 2019; ICD-10: International Code of Disease – 10th version; IQR: Interquartile Range (the difference between quartile one and quartile three); NA: Data not available due to inconsistencies in the electronic medical records (EMRs) during the study period.
The five targeted bacteria (Table 2) accounted for 78.3% and 76.2% of all non-duplicated isolates in Phu Tho Hospital and 175 Hospital, respectively. In Phu Tho Hospital, Acinetobacter species (Acinetobacter spp.) were the most prevalent (27.5%), predominantly A. baumannii, followed by Klebsiella species (Klebsiella spp.) (18.8%) and P. aeruginosa (18.1%). E. coli and S. aureus represented 10.3% and 3.6%, respectively, of the isolates. At 175 Hospital, Klebsiella spp. (mainly K. pneumoniae) were dominated (28.0%), followed by Acinetobacter spp. (25.4%), primarily A. baumannii. Among 441 Klebsiella isolates, K. aerogenes (n = 11, 2.5%) appeared only at 175 Hospital, with one isolate from a COVID-19 patient. It exhibited high resistance to cephalosporins (e.g., cefazolin 100%, ceftazidime 85.7%, ceftriaxone 72.7%) and carbapenems (imipenem/meropenem 80%) (Supplementary Table S3).
Distribution of targeted bacteria isolated from ICU patients in two hospitals
a In this study, Acinetobacter spp. was used for all kinds of Acinetobacter species.
b In this study, Klebsiella spp. was used for all kinds of Klebsiella species.
ICU: Intensive Care Unit.
For the monthly trends of bacterial isolates, Figures 1 and 2 shows that Acinetobacter spp. remained the most prevalent at Phu Tho Hospital, followed by Klebsiella spp. or P. aeruginosa (peaking in early 2020 and mid-2021). Meanwhile, Klebsiella spp. consistently dominated in 175 Hospital, except from July 2021 to March 2022, when Acinetobacter spp.’s prevalence reached the peak concurrently with the COVID-19 outbreaks in Ho Chi Minh City. During this period, P. aeruginosa cases doubled, while E. coli and S. aureus showed declining trends. Figure 3 highlights bacterial AMR among COVID-19 patients at 175 Hospital (August 2021 to April 2022) with Acinetobacter spp. peaking in October 2021 (26 isolates) and November 2021 (19 isolates). Klebsiella spp. shows the second highest number, peaking in October 2021 (18 isolates) and declining thereafter. P. aeruginosa, E. coli, and S. aureus remain low, with counts generally below five isolates per month, though P. aeruginosa shows a slight increase in December 2021 (12 isolates).
Number of antibiotic-susceptible test samples taken by month in Phu Tho Hospital.
Number of antibiotic-susceptible test samples taken by month in 175 Hospital.
Number of isolates having AMR bacteria among COVID-19 patients in 175 Hospital.
Antibiotic resistance to different antibiotics and antibiotic families
Tables 3 and 4 illustrate the resistance to the common antibiotics used in AST. Acinetobacter spp., Klebsiella spp., and P. aeruginosa exhibited high resistance rates (80–100%) to 90% of tested antibiotics, except for amikacin, colistin, trimethoprim-sulfamethoxazole, tobramycin, and doripenem, having resistance rates below 50%. The resistance of E. coli ranged from 60–80% in both hospitals. S. aureus had higher resistance rates in Phu Tho Hospital. In 175 Hospital, ESBL production was found in 35.2% of E. coli and 10.9% of Klebsiella spp. while carbapenemase production was found in 63.6% for Acinetobacter spp., 63.9% for Klebsiella spp., 52.9% for P. aeruginosa, and 16.9% for E. coli. Additionally, 66.5% of S. aureus were identified as MRSA. Both hospitals exhibited alarmingly high MDR rates, particularly elevated levels in 175 Hospital. At Phu Tho Hospital, MDR rates were 90.2% for Acinetobacter spp., 85.1% for Klebsiella spp., 87.7% for P. aeruginosa, 76.1% for E. coli, and 90.3% for S. aureus. 175 Hospital showed even higher rates for Acinetobacter spp. (95.8%) and Klebsiella spp. (90.0%) but lower MDR rates for S. aureus (51.4%).
Antibiotic resistance rate of Acinetobacter spp., Klebsiella spp., Pseudomonas aeruginosa, and Escherichia coli towards the most commonly used antibiotics in the Antibiotic Susceptibility Test
ESBL: extended-spectrum beta-lactamase.
The symbol ‘–’ indicates that the test was not applicable or not performed for that particular antibiotic-bacteria combination.
Antibiotic resistance rate of Staphylococcus aureus to the most commonly used antibiotics in the Antibiotic Susceptibility Test
The symbol ‘–’ indicates that the test was not applicable or not performed for that particular antibiotic-bacteria combination.
More detailed information on AMR bacteria categorized by cause of diagnosis admission could be found in Supplementary Table S1. In Phu Tho Hospital, Acinetobacter spp. were the most popular bacteria in patients with respiratory diseases (26.3% of positive cases), followed by P. aeruginosa (23.7%) and Klebsiella spp. (18.8%). Meanwhile, in 175 Hospital, Acinetobacter spp. were prevalent among COVID-19 patients (32.6% of cases), and Klebsiella spp. accounted for 21.8%.
Factors associated with the prevalence of AMR bacteria
Table 5 shows the results of the logistic regression model with 1,000 times of bootstrap resampling. Men were less likely to have E. coli infections compared to women (coef = −0.73, 95% CI: [−1.12, −0.33]), and older patients had a lower likelihood of S. aureus infections than younger ones (coef = −0.30, 95% CI: [−0.55, −0.04]). COVID-19 patients showed a higher prevalence of Acinetobacter spp. compared to those without COVID-19 (coef = 0.46, 95% CI: [0.03, 0.89]), but a significantly lower prevalence of AMR E. coli (coef = −1.61, 95% CI: [−2.37, −0.85]) and S. aureus (coef = −1.04, 95% CI: [−1.84, −0.25]). Patients residing in Phu Tho had a lower prevalence of Klebsiella spp. (coef = −0.59, 95% CI: [−0.91, −0.26]) but higher rates of Acinetobacter spp. (coef = 0.40, 95% CI: [0.07, 0.73]) and P. aeruginosa (coef = 0.58, 95% CI: [0.18, 0.98]) compared to those from other regions. Regarding seasonality, patients admitted in May were less likely to develop AMR in Acinetobacter spp. (coef = −0.67, 95% CI: [−1.17, −0.17]) but more likely for Klebsiella spp. (coef = 0.46, 95% CI: [0.03, 0.88]) than those not admitted in this month. These associations highlight the complex interplay of patient demographics, admission timing, and sample types in understanding AMR prevalence.
Associations between demographic and clinical indicators and the prevalence of AMR bacteria in both hospitals
AMR: Antimicrobial resistance; coef: coefficient; 95% CI: 95% confidence interval; ICD-10: International Code Diseases – 10th version; COVID-19: coronavirus disease 2019.
Discussion
This study assessed the prevalence and risk factors for AMR associated with the five key bacteria among ICU patients at Phu Tho Hospital and 175 Hospital between January 2020 and June 2022. Results revealed a high prevalence of AMR and MDR, particularly in Acinetobacter spp., Klebsiella spp., and P. aeruginosa. Acinetobacter spp. predominated in Phu Tho Hospital, while Klebsiella spp. led in 175 Hospital, where COVID-19 patients accounted for 70.1% of cases involving these bacteria. Bootstrap logistic regression analysis identified significant associations between AMR prevalence and several factors, including patient demographics (age, sex, residential location), clinical characteristics (sample type, admission diagnosis), and month of bacterial isolation.
The prevalence of AMR in targeted bacteria
In this study, the predominance of Acinetobacter spp., Klebsiella spp., and P. aeruginosa (65%–67% of all isolated samples) aligned with studies from Vietnam in 2020 [6] and other LMICs in 2021 [Reference Saharman2], particularly the exceptionally high carbapenem resistance among Klebsiella spp. and P. aeruginosa. P. aeruginosa ranked as the second-highest infection in respiratory cases at Phu Tho, mirroring its role in Southeast Asian ICUs after A. baumannii [Reference Suwantarat and Carroll29]. High carbapenem resistance in P. aeruginosa (75.5% at Phu Tho, 82.9% at 175 Hospitals) far exceeded national surveillance rates from 2020 (45.3%) [6].
Interestingly, the higher prevalence of Acinetobacter spp. compared to Klebsiella spp. in Phu Tho Hospital for the whole period were similar to a hospital ICU data in Ho Chi Minh city in 2015 (before COVID-19) [Reference Tran30]. Meanwhile, Klebsiella spp. predominated at 175 Hospital, except during the COVID-19 outbreak in Ho Chi Minh city (July 2021–January 2022), when Acinetobacter spp. increased significantly and ranked highest, which implied pandemic-related AMR selection pressures. Alarmingly, colistin resistance in Acinetobacter spp. at 175 Hospital (3.3%) doubled compared to 2015 levels (1.5%), signalling the reduced efficacy of this last-resort antibiotic [Reference Tran30].
Klebsiella spp.’s high resistance to carbapenem and third-generation cephalosporins reflected the similar trends in LMICs, such as China, India, Pakistan, Egypt, and Vietnam [Reference Saharman2] and the opposing downward trend in the United States and Europe [31]. Rising carbapenem resistance among Klebsiella spp. in Vietnam and in LMICs may be linked to carbapenemase production of K. pneumoniae [Reference Nguyen32] and natural ampC enzyme overexpression in K. aerogenes [Reference Intra33]. Risk factors for high AMR rates of Acinetobacter spp. and Klebsiella spp. in ICUs likely included ventilator-associated pneumonia (VAP) (due to high ventilator bed occupancy, particularly for COVID-19 patients [Reference Wilde34]), invasive procedures (e.g., urinary catheterization), prolonged hospitalization, weakened immune and microbiome systems [Reference Saharman2, Reference Wang35], as well as the misuse of broad-spectrum antibiotics such as cephalosporins and penicillins [Reference Nandi, Pecetta and Bloom36]. MDR rates for Acinetobacter spp. and Klebsiella spp. surpassed rates from a national study 10 years ago [Reference Vu37], likely due to overuse of cephalosporins and quinolones, prophylactic antibiotic misuse, and patient overcrowding, healthcare workers’ habit of receiving broad-spectrum antibiotics, or incomplete sterilization of the material [Reference Van Tuong38].
While this study focused on ICU patients due to their heightened AMR risk, recent literature highlights remarkable differences between ICU and non-ICU settings in Vietnam during the COVID-19 pandemic. For example, a study from a Hanoi tertiary hospital (2014–2021) reported the MRSA rate of 50% in ICU versus (vs.) 33.3% in non-ICU, Acinetobacter spp. meropenem resistance 88.0%–91.0% in ICU vs. 56.0%–58.0% in non-ICU, K. pneumoniae carbapenem resistance (6%–59% in ICU vs. 13.0%–16.0% in non-ICU, P. aeruginosa meropenem resistance 75.0% vs. 55.0% [Reference Van39], and E. coli cefotaxime resistance 62.0% vs. 49.0% [40]. National 2020 data found higher rates for MRSA (78%) and E. coli ceftriaxone resistance (67.9%) but lower for carbapenem resistance (e.g., 45.3% for P. aeruginosa, 87.8% for Acinetobacter spp.) [21]. Increased ICU antibiotic use, especially carbapenems [Reference Van39–Reference Diep41], and rising community-acquired resistance (e.g., fluoroquinolones, cephalosporins) [Reference Diep41] likely increased AMR’s pervasiveness across hospital settings. These trends underscore the need for expanded AMR surveillance across both ICU and non-ICU settings, in line with national recommendations [21].
Factors associated with the different prevalence of antibiotic-resistant bacteria
The observed regional differences in antimicrobial resistance (AMR) rates between 175 Hospital (Southern Vietnam) and Phu Tho Hospital (Northern Vietnam) reflect a complex interplay of patient demographics, antibiotic prescribing practices, infection control measures, and hospital-specific roles during the COVID-19 pandemic, as well as regional variations in antibiotic use outside hospital settings. Environmental factors, such as seasonality, may also contribute to the sporadic occurrence of AMR bacteria.
Patient demographics (e.g., age and sex) and clinical characteristics (diagnosis) are significantly associated with the prevalence of AMR bacteria. Notably, AMR E. coli and S. aureus were less likely to occur among higher age, female, and COVID-19 patients, that may reflect the unique local patient demographics, as mentioned in some studies in global and in Europe [Reference Naghavi1, Reference Waterlow42]. Geographically, Northern Vietnam (Phu Tho) showed higher Acinetobacter spp. and lower AMR Klebsiella spp. rates than the South (175 Hospital), consistent with prior Vietnamese studies highlighting regional and temporal AMR variations [Reference Vu7, 43].
Antibiotic prescribing practices and hospital roles during COVID-19 further shaped AMR patterns. As a major COVID-19 treatment centre in urban Ho Chi Minh City, 175 Hospital faced elevated AMR rates, likely due to intensified broad-spectrum antibiotic use (e.g., carbapenems) for critically ill patients during the fourth wave (April 2021–March 2022) [Reference Nguyen44, 45] which already increased the selective pressure and resistance likely increased, fostering resistant strains. High patient volumes and resource strain may have also weakened infection control, amplifying AMR spread. Conversely, Phu Tho Hospital, a rural facility not treating COVID-19, had lower AMR rates, linked to reduced antibiotic exposure and less severe cases (10 deaths among 5,500 COVID-19 cases). Conversely, Phu Tho Hospital, a rural facility not treating COVID-19, had lower AMR rates, possibly due to reduced antibiotic exposure and less severe cases (10 deaths among 5,500 COVID-19 cases) [Reference Nguyen46]. However, its higher MRSA rates compared to 175 Hospital suggest gaps in infection prevention and control (IPC), particularly in the ICU, where HAIs may have contributed [Reference Van39].
Urban settings like Ho Chi Minh City exhibited higher AMR due to dense populations, healthcare pressures, and easier antibiotic access via pharmacies, often without prescriptions, that led to AMR spread in community settings [Reference Beardsley47]. Though both hospitals are public ones and follow national IPC guidelines [Reference Nguyen44], but the effectiveness of these measures in 175 Hospital was likely compromised by patient overload and resource constraints during the pandemic [31]. For VAP, standard measures were implemented at both sites [Reference Nguyen44]. However, 175 Hospital, with more ventilated COVID-19 patients, may have experienced higher VAP rates due to resource limitations, reflecting pre-pandemic trends in Vietnamese central hospitals where Acinetobacter, Klebsiella, and P. aeruginosa were predominant [Reference Vu7, Reference Hayakawa48]. Besides, the antibiotic stewardship programs (e.g., antibiotic prescription committees, usage monitoring) were in place at both hospitals, but 175 Hospital struggled more with broader-spectrum antibiotic use, a pattern also observed in other Western Pacific and Southeast Asian countries [43].
Seasonal factors also influenced AMR, with lower Acinetobacter spp. rates in May, possibly tied to climate variations like humidity, which possibly affected the spread and resistance of respiratory pathogens [Reference Suwantarat and Carroll29]. These findings emphasize the importance of integrating patient, hospital, regional, and environmental factors into AMR surveillance and control strategies in Vietnam.
Strengths and limitations
This study is among the few in Vietnam and Southeast Asia that utilized EMR to examine the prevalence of AMR and identify associated factors. However, several limitations must be acknowledged. First, the retrospective design and pandemic context may have introduced some kinds of bias. Selection bias may arise from milder cases avoiding care, information bias from inconsistent COVID-19 testing accuracy, and unmeasured confounding from undocumented comorbidities or non-ICU antibiotic use (e.g., outpatient or other ward departments). Reliance on EMRs risks misclassification due to incomplete antibiotic histories, and the inability to distinguish community- from hospital-acquired infections restricts insight into nosocomial spread.
Second, methodological constraints include inter-hospital variability in laboratory protocols and the lack of reference laboratory confirmation for AST results [49], potentially underestimating resistance rates. Uneven sampling and incomplete testing of antibiotic families across patients and study sites may further skew resistance rates. Furthermore, the COVID-19 pandemic likely influenced the sampling strategy, with clinicians potentially prioritizing COVID-19 patients for testing. Besides, limited resources and capability in Vietnam’s laboratories during and even before the pandemic – where AST is primarily performed for severe cases at provincial/central hospitals [Reference Van Tuong38, 45] – likely led to over-sampling of resistant infections, potentially inflating AMR rates.
Finally, unmeasured factors like residency patterns, microbiome influences, and dietary antibiotic exposure [Reference Wang35], could further affect AMR patterns. While these limitations are typical of retrospective EMR studies, they highlight the needs for future prospective designs with standardized data collection.
Conclusion
This study of 2,432 electronic medical records from 1,296 patients at 175 Hospital and Phu Tho Hospital revealed distinct AMR patterns in ICUs: Acinetobacter spp. predominated at Phu Tho Hospital, while Klebsiella spp. were most prevalent at 175 Hospital, with resistance rates for cephalosporins, carbapenems, and fluoroquinolones ranging from 75% to 100%, and MDR rates at 83.8%–95.8%. This study also highlights the associations between AMR prevalence in Vietnam ICUs and local factors, including patient demographics (age, sex), clinical characteristics (sample types, comorbidities), seasonality, and COVID-19 admissions. The findings underscore the need for tailored antibiotic stewardship programmes, robust infection control practices, and continuous regional surveillance, particularly in high-risk settings like ICUs, to address such disparities effectively. Future research should explore how community-level resistance, potentially elevated during the pandemic, influences hospital AMR rates across these regions.
Abbreviations
- A. baumannii
-
A. baumannii
- AI
-
Artificial Intelligence
- AMR
-
Antimicrobial resistance
- AST
-
Antimicrobial Susceptibility Testing
- ATCC
-
American Type Culture Collection
- BD Phoenix
-
Becton Dickinson Phoenix
- CI
-
Confidence interval
- CLSI
-
Laboratory Standards Institute
- coef
-
Coefficient
- COVID-19
-
Coronavirus Disease 2019
- E. coli
-
E. coli
- EMR
-
Electronic medical record
- ESBL
-
Extended-spectrum beta-lactamase
- GDP
-
Gross domestic product
- GLASS
-
Global Antimicrobial Resistance Surveillance
- HAI
-
Hospital-acquired infections
- HICs
-
High-income countries
- ICD-10
-
International Code of Diseases – 10th version
- ICUs
-
Intensive Care Units
- IQR
-
Interquartile Range
- LMICs
-
Low- and middle-income countries
- MDR
-
Multidrug resistance
- ML
-
Machine learning
- MRSA
-
Methicillin-resistant S. aureus
- P. aeruginosa
-
P. aeruginosa
- S. aureus
-
S. aureus
- SD
-
Standard deviation
- USD
-
US Dollar
- VAP
-
Ventilator-associated pneumonia
- VIF
-
Variance Inflation Factor
- WHO
-
World Health Organization
Supplementary material
The supplementary material for this article can be found at http://doi.org/10.1017/S0950268825100307.
Data availability statement
The data are not publicly available due to sensitivity reasons but are available upon reasonable request to the corresponding author (dda.icd@gmail.com).
Acknowledgements
The authors would like to acknowledge the Honjo International Foundation Scholarship for providing a scholarship to Dr. Do Dang An during his PhD. We thank the Department of Community and Global Health of the University of Tokyo for supporting the main author to complete this study. We are also grateful to Assoc. Nguyen Hong Son, former director of Military Hospital 175, and Mr. Nguyen Thanh Cuong, head of the International Cooperation Department in Phu Tho Provincial General Hospital, for organizing the study protocol and collecting the data.
Author contribution
Dang-An Do: Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft [Corresponding author].
Minh-Duy Nguyen-Vu: Data curation, Investigation, Methodology.
Thi-Hang Nguyen: Conceptualization, Data curation, Investigation, Methodology.
Dinh-Thanh-Son Le: Investigation, Project administration, Supervision.
Huy-Ngoc Nguyen: Project administration, Supervision, Writing – review & editing.
Duc-Nhu Dang: Conceptualization, Methodology, Supervision, Validation, Writing – review & editing.
Competing interests
The authors declare none.
Ethical standard
The study was approved by the Research Ethics Committee of the University of Tokyo (for the first time, approval was given at 2021328NI on 24 January 2022, and the amended version was approved at 2021328NI - (1) on 4 November 2022). In Vietnam, the study was approved by the Institutional Research Boards of Ethics Committee at Hanoi University of Public Health (approval number 022–357 DD/YTCC on 2 August 2022) and at 175 Hospital (approval number 911/GCN-HDDD on 24 March 2023). The study was carried out in compliance with the principles of the Declaration of Helsinki. The informed consent from patients to participate in this study was uneccessary according to the Vietnamese regulations (Law No. 40/2009/QH12 issued on 23 November 2009 and Law No. 15/2023/QH15 issued on 9 January 2023 on Medical Examination and Treatment, and the Circular 46/2018/TT-BYT on the Regulation of Electrical Medical Record). The need for informed consent was also waived by the Research Ethics Committee of the University of Tokyo and the Research Boards of Ethics Committee of Hanoi University of Public Health. Only EMRs of patients from 18 years old at the time of hospital admission (from 1 January 2020 to 30 June 2022) were collected. Confidentiality was strictly maintained throughout the study to protect patient privacy.
Open access
